OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

2.28
Delayed Data
As of May 27
 +0.12 / +5.56%
Today’s Change
1.74
Today|||52-Week Range
4.33
-0.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues4.9M4.8M5.7M1.4M
 
 
 
 
 
Depreciation And Amortization55.0K55.0K58.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.5M12.0M12.5M6.4M
 
 
 
 
 
Research And Development9.9M9.6M9.9M3.7M
 
 
 
 
 
Total Operating Expenses12.6M12.0M12.6M6.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.6M-7.2M-6.9M-5.0M
 
 
 
 
 
Extraordinary Credit615.0K2.9M267.0K--
 
 
 
 
Extraordinary Charge0.00-531.0K----
 
 
Other Expenses-4.0K-11.0K967.0K480.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.0M-4.9M-5.7M-4.5M
 
 
 
 
 
Net Income-7.0M-4.9M-5.7M-4.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.0M21.1M21.5M22.7M
 
 
 
 
 
Shares To Calculate EPS Diluted15.0M21.1M21.5M22.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47-$0.23-$0.26-$0.20
 
 
 
 
 
EPS Diluted-$0.47-$0.23-$0.26-$0.20
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account